Figure 1

Remark diagram showing patients randomized to the parent clinical trials and those included in the present cohort for analysis of p53 expression. CMF, cyclophosphamide, methotrexate, 5-fluorouracil; FISH, fluorescent in situ hybridisation; HER, human epidermal growth factor receptor 2.